Menu

Experience

Dani Nazemian

    • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 


    • AveXis – $95 Million IPO 


    • Dot Hill Systems sale to Seagate Technology 


    • ProNAi Therapeutics - $158 Million IPO 


    • ProNAi – $158 Million IPO 


    • Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion 


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Invitae Completes $117 Million Initial Public Offering  


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Otonomy $100 Million IPO 


    • HealthEquity $146 Million Initial Public Offering 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Amedica Initial Public Offering 


    • Flexion $74 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Celladon Initial Public Offering 


Contact us

Back to top

© 2021 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.